Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intellia Therapeutics Inc buy Morgan Stanley

Intellia Therapeutics Inc
Start price
€21.86
13.11.23 / 50%
Target price
€79.49
13.11.24
Performance (%)
-29.07%
End price
€15.51
14.11.24
Summary
This prediction ended on 14.11.24 with a price of €15.51. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.07%. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Intellia Therapeutics Inc 22.436% 22.436% -1.308%
iShares Core DAX® 2.331% 5.140% 25.000%
iShares Nasdaq 100 2.077% 2.956% 8.935%
iShares Nikkei 225® 2.759% 7.214% 22.171%
iShares S&P 500 1.613% 2.893% 6.249%

Comments by Morgan_Stanley for this prediction

In the thread Intellia Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -29.07%
Target price 79.492
Change
Ends at 13.11.24

Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Morgan Stanley from $90.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat

Morgan Stanley 
0
Report Share
13.11.23
In the thread Trading Intellia Therapeutics Inc
Prediction Buy
Perf. (%) -29.07%
Target price 79.492
Change
Ends at 13.11.24

Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten

Morgan Stanley 
0
Report Share
14.11.24